Microbial Fermentation as a Sustainable Route for Green Active Pharmaceutical Ingredient (API) Production: Advances, Challenges, and Future Perspectives | Synapse
Microbial Fermentation as a Sustainable Route for Green Active Pharmaceutical Ingredient (API) Production: Advances, Challenges, and Future Perspectives
This research aims to explore microbial fermentation as a sustainable method for producing active pharmaceutical ingredients (APIs).
Discussed advances in microbial fermentation techniques for API production.
Examined challenges faced in bioprocess optimization and genetic engineering methods.
Outlined future perspectives for sustainable drug production through biomanufacturing.
Identified several advantages of microbial fermentation over traditional methods.
Highlighted challenges such as scalability and regulatory hurdles.
Discussed potential solutions for optimizing bioprocesses and genetic engineering applications.
Abstract
Abstract: Active pharmaceutical ingredients (APIs), green biomanufacturing, microbial fermentation, metabolic and genetic engineering, bioprocess optimization, sustainable drug production.